New research describes a preventive treatment paradox in advanced age

Website intended for a NZ health professional readership

+Practice

In print

OLDER PEOPLE

New research describes a preventive treatment paradox in advanced age

16 March 2022

Ngaire Kerse

Wednesday 16 March 2022, 12:35 AM

Women were found to be less likely to receive triple therapy [Image: SelectStock on iStock]

Professor Ngaire Kerse summarises recent research carried out at the University of Auckland into the use of cardiovascular disease preventive medications in people aged 65 and over

Key points, Recent research shows that the cardiovascular disease preventive medications most likely to cause harm are those most likely to be dispensed to older , Pract Green w Pale Yellow

Wells S, Choi Y, Jackson R, et al. Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox? Age Ageing 2022;51(1):afab265.

How to Treat

+How to treat

Heart failure

Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality

Wednesday 29 January 2025, 12:45 AM